According to Altamira Therapeutics's latest financial reports and stock price the company's current Operating Margin is -26,891.50%. At the end of 2021 the company had an Operating Margin of -26,891.54%.
Year | Operating Margin | Change |
---|---|---|
2021 | -26,891.54% | 480.23% |
2020 | -4,634.65% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.